Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Articles published by Baudax Bio, Inc.
Baudax Bio Reports First Quarter Financial Results and Provides Business Update
May 12, 2023
From
Baudax Bio, Inc.
Via
GlobeNewswire
Tickers
BXRX
Baudax Bio to Present at the Sidoti Virtual Investor Conference
May 03, 2023
From
Baudax Bio, Inc.
Via
GlobeNewswire
Tickers
BXRX
Baudax Bio Announces Closing of $4 Million Public Offering
May 01, 2023
From
Baudax Bio, Inc.
Via
GlobeNewswire
Tickers
BXRX
Baudax Bio Announces Pricing of $4 Million Public Offering
April 26, 2023
From
Baudax Bio, Inc.
Via
GlobeNewswire
Tickers
BXRX
Baudax Bio Announces Positive Top-Line Final Results From Phase 2 Randomized Clinical Trial of BX1000
April 25, 2023
From
Baudax Bio, Inc.
Via
GlobeNewswire
Tickers
BXRX
Baudax Bio to Host Key Opinion Leader Webinar to Discuss Results of Phase 2 BX1000 Trial
April 24, 2023
From
Baudax Bio, Inc.
Via
GlobeNewswire
Tickers
BXRX
Baudax Bio Announces Positive Results from 2nd Interim Analysis of Phase 2 Randomized Trial for BX1000
March 27, 2023
From
Baudax Bio, Inc.
Via
GlobeNewswire
Tickers
BXRX
Baudax Bio Reports 2022 Fourth Quarter and Annual Financial Results and Provides Business Update
February 23, 2023
From
Baudax Bio, Inc.
Via
GlobeNewswire
Tickers
BXRX
Baudax Bio Announces Positive Outcome of Interim Analysis of Phase II Randomized Trial for BX1000
January 24, 2023
From
Baudax Bio, Inc.
Via
GlobeNewswire
Tickers
BXRX
Baudax Bio Initiates Phase II Clinical Trial Evaluating BX1000 in Patients Undergoing Surgery
December 08, 2022
From
Baudax Bio, Inc.
Via
GlobeNewswire
Tickers
BXRX
Baudax Bio Announces Closing of $5 Million Public Offering
December 06, 2022
From
Baudax Bio, Inc.
Via
GlobeNewswire
Tickers
BXRX
Baudax Bio Announces Pricing of $5 Million Public Offering
December 02, 2022
From
Baudax Bio, Inc.
Via
GlobeNewswire
Tickers
BXRX
Baudax Bio Announces 1-for-40 Reverse Stock Split
November 30, 2022
From
Baudax Bio, Inc.
Via
GlobeNewswire
Tickers
BXRX
Baudax Bio Reports Third Quarter 2022 Financial Results and Business Highlights
November 08, 2022
From
Baudax Bio, Inc.
Via
GlobeNewswire
Tickers
BXRX
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today